Objective

Commentators seize on instances of bad practise in the pharmaceutical industry. So they should - all business sectors have a responsibility to behave with integrity. But the vitriol that is directed at pharma appears disproportionately excessive, especially for an industry that has saved and improved the lives of hundreds of millions of people. How have we reached a situation where one of the most important sectors affecting human health has become the enemy and an easy target? And more importantly, how do we reverse this? The speaker will argue that the issues identified by the most vocal opponents of the industry are symptoms of a deeper problem, not causes. In this session the speaker will offer her thoughts on how we have ended up in this situation and what we need to do to improve it while we still have the chance